Display options
Share it on

J Pers Med. 2020 Sep 22;10(3). doi: 10.3390/jpm10030140.

A Data-Driven Approach to Carrier Screening for Common Recessive Diseases.

Journal of personalized medicine

Anna V Kiseleva, Marina V Klimushina, Evgeniia A Sotnikova, Mikhail G Divashuk, Alexandra I Ershova, Olga P Skirko, Olga V Kurilova, Anastasia A Zharikova, Eleonora Yu Khlebus, Irina A Efimova, Maria S Pokrovskaya, Petr A Slominsky, Svetlana A Shalnova, Alexey N Meshkov, Oxana M Drapkina

Affiliations

  1. Federal State Institution «National Medical Research Center for Therapy and Preventive Medicine» of the Ministry of Healthcare of the Russian Federation, Petroverigsky per., 10, bld. 3, 101000 Moscow, Russia.
  2. Kurchatov Genomics Center-ARRIAB, All-Russia Research Institute of Agricultural Biotechnology, Timiryazevskaya Street, 42, 127550 Moscow, Russia.
  3. Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Leninskie Gory, 1-73, 119991 Moscow, Russia.
  4. Institute for Information Transmission Problems, Russian Academy of Sciences, Bol'shoi Karetnyi per., 19, 127051 Moscow, Russia.
  5. Institute of Molecular Genetics, Russian Academy of Sciences, Kurchatov Sq., 2, 123182 Moscow, Russia.

PMID: 32971794 PMCID: PMC7563953 DOI: 10.3390/jpm10030140

Abstract

Genetic screening is an advanced tool for reducing recessive disease burden. Nowadays, it is still unclear as to the number of genes or their variants that are necessary for effective screening. This paper describes the development of a carrier screening custom panel for cystic fibrosis, phenylketonuria, alpha-1 antitrypsin deficiency, and sensorineural hearing loss consisting of 116 variants in the

Keywords: CFTR; GJB2; PAH; SERPINA1; alpha-1 antitrypsin deficiency; carrier screening; cystic fibrosis; phenylketonuria; sensorineural hearing loss

References

  1. Genet Med. 2019 Sep;21(9):1940-1947 - PubMed
  2. Genet Med. 2002 Jul-Aug;4(4):258-74 - PubMed
  3. Int J Chron Obstruct Pulmon Dis. 2017 Feb 13;12:561-569 - PubMed
  4. Gut. 2019 Jun;68(6):1099-1107 - PubMed
  5. Mol Genet Genomic Med. 2019 Nov;7(11):e964 - PubMed
  6. Nat Rev Genet. 2015 Jan;16(1):45-56 - PubMed
  7. Genet Med. 2011 Feb;13(2):166-72 - PubMed
  8. J Cyst Fibros. 2010 Jan;9(1):29-35 - PubMed
  9. Genet Med. 2016 Dec;18(12):1244-1249 - PubMed
  10. Genet Med. 2014 Jul;16(7):539-46 - PubMed
  11. BMC Genet. 2016 Feb 19;17:45 - PubMed
  12. Genetika. 2012 Apr;48(4):542-50 - PubMed
  13. Expert Rev Mol Diagn. 2014 Jul;14(6):655-71 - PubMed
  14. Genet Med. 2018 Apr;20(5):513-523 - PubMed
  15. J Cyst Fibros. 2020 Mar;19 Suppl 1:S10-S14 - PubMed
  16. Vestn Otorinolaringol. 2014;(2):37-43 - PubMed
  17. Am J Gastroenterol. 2008 Aug;103(8):2136-41; quiz 2142 - PubMed
  18. Ann N Y Acad Sci. 1991;630:16-31 - PubMed
  19. BMC Med Genet. 2013 Oct 24;14:112 - PubMed
  20. Nature. 2020 May;581(7809):434-443 - PubMed
  21. Genet Med. 2003 May-Jun;5(3):161-5 - PubMed
  22. Hum Mutat. 2003 Apr;21(4):345-56 - PubMed
  23. Acta Naturae. 2011 Jul;3(3):52-63 - PubMed
  24. Methods Mol Biol. 2020;2065:199-208 - PubMed
  25. Eur J Hum Genet. 2016 Jun;24(6):e1-e12 - PubMed
  26. Curr Med Chem. 2017;24(1):65-90 - PubMed
  27. Hum Mutat. 1998;11(5):387-94 - PubMed
  28. Orphanet J Rare Dis. 2008 Jun 19;3:16 - PubMed
  29. Obstet Gynecol. 2017 Mar;129(3):e35-e40 - PubMed
  30. PLoS One. 2016 May 25;11(5):e0156300 - PubMed
  31. J Med Genet. 2001 Jan;38(1):20-5 - PubMed
  32. Am J Hum Genet. 1998 Apr;62(4):792-9 - PubMed

Publication Types